Trimecain in prevention of coughing after endoscopic ENT surgery in paediatric patients
Authors:
T. Vymazal 1; M. Marková 2; E. Mikešová 2
Authors‘ workplace:
KAR 2. LF UK a IPVZ, Motol, přednosta doc. MUDr. Karel Cvachovec, CSc. 2 Klinika ORL 2. LF UK, Motol, přednosta doc. MUDr. Zdeněk Kabelka
Published in:
Anest. intenziv. Med., , 1999, č. 1, s. 14-16
Category:
Overview
We sought to determine the effect of intravenously administered trimecain (Mesocain 1%, Leciva, CZ) in strictly defined dose and time ofadministration to prevent coughing during recovery from general anaesthesia for endoscopic ENT surgery in paediatric patients. We also followedthe effect of IV trimecain on heart rate, blood pressure, capillary haemoglobin saturation and time to response to verbal command during recovery ofpaediatric patients. We found that administration of trimecain in the dose 1 mg/kg 2–3 mins before the end of general anaesthesia significantly reducesthe occurrence and intensity of coughing after instrumentation in upper and lower respiratory tract in paediatric patients, diminishing the risksassociated with this stage of operation. This amount of trimecain does not possess any adverse effects of hemodynamic parameters in hemodynamicallystable paediatric patients.
Key words:
cough – endoscopic ENT surgery – paediatric anaesthesia for ENT surgery
Labels
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineArticle was published in
Anaesthesiology and Intensive Care Medicine
1999 Issue 1
Most read in this issue
- The evaluation of accuracy of prediction of survival probability in trauma patients according to APACHE II, ISS and TRISS
- Trimecain in prevention of coughing after endoscopic ENT surgery in paediatric patients
- General anaesthesia with sevoflurane using VIMA technique
- Hemodynamic and oxygen transport parameters in critically ill patients